CoChat

Therapeutic Potential for HDAC Inhibitors in the Heart

McKinsey, Timothy A. · 2012 · Annual Review of Pharmacology and Toxicology

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Abstract

Reversible protein acetylation provides a central mechanism for controlling gene expression and cellular signaling events. Two pharmacological inhibitors of protein deacetylation are currently approved for the treatment of human cancer, and numerous follow-on compounds are in clinical development for oncology and non-oncology indications. The inhibitors target members of a family of enzymes known as histone deacetylases (HDACs). Surprisingly, HDAC inhibitors have also been shown to be efficacious in preclinical models of heart failure. This review highlights roles of HDACs in the heart and the therapeutic potential of HDAC inhibitors for the treatment of heart failure.

Overview

Integrity signals

Registry

Crossref · 10.1146/annurev-pharmtox-010611-134712

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 98 references

Research works printed but not linked: 4

  1. 10.1161/hypertensionaha.110.154567 · DOI · Paper page
  2. 10.1111/j.1476-5381.2010.00637.x · DOI
  3. 10.1161/circulationaha.105.559724 · DOI · Paper page
  4. 10.2119/molmed.2011.00030 · DOI

Cited by

See all 239

Metadata

Authors
McKinsey, T. A.
Affiliations
University of Colorado Anschutz (US)
Corresponding author
McKinsey, Timothy A.
Venue
Annual Review of Pharmacology and Toxicology
Published
2012-02-10
Volume
52
Issue
1
Pages
303-319
ISSN
  • 0362-1642 (ISSN-L)
  • 1545-4304
OpenAlex
W2103908660
Cited by
230
References
98
Citations by year
2026: 5 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 14 · 2021: 11 · 2020: 19 · 2019: 22 · 2018: 21 · 2017: 22 · 2016: 22 · 2015: 19 · 2014: 20 · 2013: 17 · 2012: 11
FWCI
1.42
Type
journal article
Language
en
Open access
closed
Locations
  • The Annual Review of Pharmacology and Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
histone deacetylase inhibitors, heart failure, protein acetylation, protein deacetylation, cardiac gene expression, cardiac signaling
MeSH terms
Acetylation, Animals, Drug Evaluation, Preclinical, Heart, Heart Failure, Histone Deacetylases, Histones, Humans, Models, Biological, Ventricular Remodeling, Models, Animal, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic Potential for HDAC Inhibitors in the Heart. https://app.cochat.ai/papers/10.1146/annurev-pharmtox-010611-134712
The paper
McKinsey, T. A. (2012). Therapeutic Potential for HDAC Inhibitors in the Heart. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev-pharmtox-010611-134712

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.